EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study

Mitchell A Jeffs iD, Nicole Li iD, Oluwalade Ogunkoya, D Brody Duncan, Carson K L Lo iD, Clayton W Hall iD, Ameera Nemer iD, Elaf Alzarnougi, Calvin Ka-Fung Lo iD, Emma B Monti, Thuwiba Al Baluki iD, Zong Heng Shi iD und 4 weitere

The Journal of Infectious Diseases · 16.06.2026 · 233 (6) · e1433-e1442

DOI: 10.1093/infdis/jiag199 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 02.04.2026. Verfasst von Mitchell A Jeffs und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada. Hauptthemen laut MEDLINE: Cefazolin, Anti-Bacterial Agents, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Department of Medicine, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It remains unclear if cefazolin inoculum effect (CzIE) translates to poorer clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) infections who were treated with cefazolin.

Methods

This retrospective cohort study across 5 hospitals in Ontario, Canada, from 2021 to 2025 included adult patients who received cefazolin treatment for serious MSSA infection based on blood or deep sterile site culture growth. CzIE was defined as a ≥4-fold increase in cefazolin minimum inhibitory concentration to ≥16 μg/mL at a high inoculum based on broth microdilution assay. Patients were followed to 90 days. Primary outcome was all-cause mortality. Secondary outcome was microbiological treatment failure based on culture growth of MSSA after 1 week of cefazolin treatment. Potential confounders were adjusted using propensity score weighting, and a competing risk model for microbiological treatment failure was used to account for mortality as a competing event.

Results

Of 259 patients, 92 (35.5%) patients had an MSSA isolate that displayed CzIE. The 90-day mortality rate was 19/92 (20.7%) and 37/167 (22.2%) in the CzIE-positive and -negative groups, respectively, with adjusted risk difference of 0.6% (95% CI, −9.0% to 10.2%; P = .9060). Microbiological treatment failure occurred in 19/92 (20.7%) and 10/167 (6.0%) from the CzIE-positive and -negative groups, respectively, with adjusted subdistribution hazard ratio of 3.12 (95% CI, 1.38–7.08; P = .0065) in a competing risk model.

Conclusions

CzIE was associated with a significantly increased risk of microbiological treatment failure. CzIE testing may be useful in guiding antibiotic treatment for serious MSSA infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefazolinAnti-Bacterial AgentsStaphylococcal InfectionsStaphylococcus aureusHumansRetrospective StudiesMicrobial Sensitivity TestsFemaleTreatment FailureMaleAgedMiddle AgedOntarioMethicillinFirst Generation CephalosporinsAged, 80 and over

Stichwörter der Autor:innen

Staphylococcus aureusantibiotic treatmentcefazolin inoculum effect

Substanzen

CefazolinAnti-Bacterial AgentsMethicillinFirst Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
  • Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • School of Medicine, Queen's University, Kingston, Ontario, Canada.

ORCID-Profile: Mitchell A Jeffs, Nicole Li, Carson K L Lo, Clayton W Hall, Ameera Nemer, Calvin Ka-Fung Lo, Thuwiba Al Baluki, Zong Heng Shi, Xena X Li, Christopher T Lohans, Anthony D Bai

Förderung

  • CIHR
  • Department of Medicine
  • Canadian Institutes of Health Research

Zitieren

APA

Jeffs, M. A., Li, N., Ogunkoya, O., Duncan, D. B., Lo, C. K. L., Hall, C. W., Nemer, A., Alzarnougi, E., Lo, C. K., Monti, E. B., Al Baluki, T., Shi, Z. H., Li, X. X., Sheth, P. M., Lohans, C. T., & Bai, A. D. (2026). Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study. The Journal of Infectious Diseases, 233(6), e1433-e1442. https://doi.org/10.1093/infdis/jiag199

Vancouver

Jeffs MA, Li N, Ogunkoya O, Duncan DB, Lo CKL, Hall CW, et al. Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study. The Journal of Infectious Diseases. 2026;233(6):e1433-e1442. doi:10.1093/infdis/jiag199

BibTeX
@article{Jeffs2026,
  author = {Jeffs, Mitchell A and Li, Nicole and Ogunkoya, Oluwalade and Duncan, D Brody and Lo, Carson K L and Hall, Clayton W and Nemer, Ameera and Alzarnougi, Elaf and Lo, Calvin Ka-Fung and Monti, Emma B and Al Baluki, Thuwiba and Shi, Zong Heng and Li, Xena X and Sheth, Prameet M and Lohans, Christopher T and Bai, Anthony D},
  title = {Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {233},
  number = {6},
  pages = {e1433--e1442},
  doi = {10.1093/infdis/jiag199}
}
Kostenlos starten →